ASX - By Stock
|
AVR |
Re:
AGM 2024 questions - please submit here.
|
|
Investek
|
93 |
26K |
0 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
93
|
26K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
First VIV in Europe! Great outcome.
|
|
Investek
|
32 |
8.8K |
1 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
32
|
8.8K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
AGM 2024 questions - please submit here.
|
|
Investek
|
93 |
26K |
5 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
93
|
26K
|
5
|
|
ASX - By Stock
|
CUV |
Re:
Ann: CLINUVEL starts global Phase III vitiligo study
|
|
Investek
|
9 |
3.9K |
2 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
9
|
3.9K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Here we go.
|
|
Investek
|
2 |
1.1K |
5 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
2
|
1.1K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Here we go.
|
|
Investek
|
2 |
1.1K |
24 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
2
|
1.1K
|
24
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Change of Director's Interest Notice
|
|
Investek
|
18 |
7.3K |
10 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
18
|
7.3K
|
10
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Change of Director's Interest Notice
|
|
Investek
|
18 |
7.3K |
7 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
18
|
7.3K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Anteris to Present at Cantor Healthcare Conference
|
|
Investek
|
73 |
27K |
11 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
73
|
27K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4D and Half Year Financial Report Announcement
|
|
Investek
|
9 |
4.7K |
10 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
9
|
4.7K
|
10
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in substantial holding
|
|
Investek
|
17 |
4.2K |
0 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
17
|
4.2K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
Investek
|
42 |
12K |
2 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
42
|
12K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
Investek
|
42 |
12K |
11 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
42
|
12K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
Investek
|
42 |
12K |
7 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
42
|
12K
|
7
|
|
ASX - By Stock
|
PNV |
Re:
Integra warns impact of plant closure will continue into 2024, with delays possible
|
|
Investek
|
92 |
29K |
2 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
92
|
29K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
Integra warns impact of plant closure will continue into 2024, with delays possible
|
|
Investek
|
92 |
29K |
2 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
92
|
29K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
Investek
|
42 |
12K |
2 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
42
|
12K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
Investek
|
42 |
12K |
3 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
42
|
12K
|
3
|
|
ASX - By Stock
|
PNV |
Re:
Short Activity in PNV
|
|
Investek
|
6.8K |
2.0M |
0 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
6.8K
|
2.0M
|
0
|
|
ASX - By Stock
|
AVR |
Re:
EFS details posted to official US government site
|
|
Investek
|
55 |
20K |
0 |
30/07/23 |
30/07/23 |
ASX - By Stock
|
55
|
20K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
EFS details posted to official US government site
|
|
Investek
|
55 |
20K |
7 |
29/07/23 |
29/07/23 |
ASX - By Stock
|
55
|
20K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
J & J Professes Voracious Appetite for Medtech M & A
|
|
Investek
|
16 |
7.0K |
0 |
22/07/23 |
22/07/23 |
ASX - By Stock
|
16
|
7.0K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
J & J Professes Voracious Appetite for Medtech M & A
|
|
Investek
|
16 |
7.0K |
1 |
22/07/23 |
22/07/23 |
ASX - By Stock
|
16
|
7.0K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
J & J Professes Voracious Appetite for Medtech M & A
|
|
Investek
|
16 |
7.0K |
2 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
16
|
7.0K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Price
|
|
Investek
|
37 |
13K |
0 |
13/07/23 |
13/07/23 |
ASX - By Stock
|
37
|
13K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Latest Patient Group Show Best Results to Date at 30 Days
|
|
Investek
|
107 |
36K |
0 |
13/06/23 |
13/06/23 |
ASX - By Stock
|
107
|
36K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: AGM Chairman Address and CEO Presentation
|
|
Investek
|
27 |
10K |
3 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
27
|
10K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
AGM questions for submission to management
|
|
Investek
|
37 |
15K |
1 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
37
|
15K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
AGM questions for submission to management
|
|
Investek
|
37 |
15K |
3 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
37
|
15K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: FIH Results Presented at EuroPCR & Simultaneous Publication
|
|
Investek
|
21 |
6.9K |
4 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
21
|
6.9K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Investek
|
16 |
6.9K |
10 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
16
|
6.9K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Investek
|
16 |
6.9K |
10 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
16
|
6.9K
|
10
|
|
ASX - By Stock
|
BRK |
Re:
Banter and General Comments .. BRK
|
|
Investek
|
11K |
3.6M |
21 |
08/04/23 |
08/04/23 |
ASX - By Stock
|
11K
|
3.6M
|
21
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Commercial Update SCENESSE
|
|
Investek
|
13 |
7.8K |
1 |
13/03/23 |
13/03/23 |
ASX - By Stock
|
13
|
7.8K
|
1
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Relief from Quarterly Reporting
|
|
Investek
|
4 |
2.6K |
3 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
4
|
2.6K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
Investek
|
78 |
26K |
1 |
03/02/23 |
03/02/23 |
ASX - By Stock
|
78
|
26K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
Investek
|
78 |
26K |
3 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
78
|
26K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Investek
|
26 |
9.3K |
2 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
26
|
9.3K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
FDA submission for early feasibility study
|
|
Investek
|
64 |
28K |
10 |
21/11/22 |
21/11/22 |
ASX - By Stock
|
64
|
28K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
FDA submission for early feasibility study
|
|
Investek
|
64 |
28K |
5 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
64
|
28K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
FDA submission for early feasibility study
|
|
Investek
|
64 |
28K |
2 |
22/09/22 |
22/09/22 |
ASX - By Stock
|
64
|
28K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Results Demonstrating Restoration of Normal Pre-Disease Flow
|
|
Investek
|
13 |
5.1K |
5 |
19/09/22 |
19/09/22 |
ASX - By Stock
|
13
|
5.1K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
NasDaq listing
|
|
Investek
|
42 |
10K |
2 |
16/09/22 |
16/09/22 |
ASX - By Stock
|
42
|
10K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
FDA submission for early feasibility study
|
|
Investek
|
64 |
28K |
3 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
64
|
28K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
FDA submission for early feasibility study
|
|
Investek
|
64 |
28K |
4 |
24/08/22 |
24/08/22 |
ASX - By Stock
|
64
|
28K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
FDA submission for early feasibility study
|
|
Investek
|
64 |
28K |
4 |
24/08/22 |
24/08/22 |
ASX - By Stock
|
64
|
28K
|
4
|
|
ASX - By Stock
|
CUV |
Re:
CUV Charting
|
|
Investek
|
131 |
67K |
0 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
131
|
67K
|
0
|
|
ASX - By Stock
|
BRK |
Re:
Banter and General Comments .. BRK
|
|
Investek
|
11K |
3.6M |
3 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
11K
|
3.6M
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Investek
|
59 |
21K |
0 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
59
|
21K
|
0
|
|
ASX - By Stock
|
BRK |
Re:
Banter and General Comments .. BRK
|
|
Investek
|
11K |
3.6M |
3 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
11K
|
3.6M
|
3
|
|